Holt-Oram syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:392OMIM:142900Q87.2
Who is this for?
Show terms as
22Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Holt-Oram syndrome (HOS), also known as heart-hand syndrome or atriodigital dysplasia, is a rare genetic disorder characterized by upper limb skeletal abnormalities and congenital heart defects. It is caused by mutations in the TBX5 gene located on chromosome 12q24.1, which encodes a transcription factor critical for the development of the heart and upper limbs during embryonic growth. The condition affects both the musculoskeletal and cardiovascular systems, with highly variable expressivity even within the same family. Upper limb abnormalities are present in all affected individuals and range from subtle changes such as a triphalangeal or absent thumb, to more severe malformations including hypoplasia or absence of the radius, and phocomelia. These skeletal anomalies are typically bilateral but often asymmetric, with the left side more severely affected than the right. Congenital heart defects occur in approximately 75% of patients, most commonly ostium secundum atrial septal defects (ASD) and ventricular septal defects (VSD). Cardiac conduction abnormalities, including atrioventricular block and atrial fibrillation, may also occur and can be progressive, sometimes developing even in the absence of structural heart defects. There is no cure for Holt-Oram syndrome, and management is directed at the specific manifestations in each individual. Cardiac defects may require surgical repair or catheter-based intervention, and patients with conduction abnormalities may need pacemaker implantation. Orthopedic interventions, including surgery or prosthetics, may be considered for significant upper limb malformations. Regular cardiac monitoring, including electrocardiography and echocardiography, is recommended throughout life due to the risk of progressive conduction disease. Genetic counseling is important for affected families given the autosomal dominant inheritance pattern and the 50% recurrence risk for offspring of an affected individual.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormal humerus morphologyHP:0031095Atrioventricular blockHP:0001678Paroxysmal atrial fibrillationHP:0004757Absent thumbHP:0009777First degree atrioventricular blockHP:0011705
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
May 2026Peer Support for Liver Transplant Recipients With History of ALD

Johns Hopkins University — NA

TrialNOT YET RECRUITING
Apr 2026A Natural History of Cardiometabolic Disease Among US Bhutanese: Developing the Cross-Sectional Bhutanese Community of Central Ohio Health Study to Understand Acculturation as Synergizing Socioenvironmental and Biobehavioral Risk Factors Propagating ...

National Institute of Environmental Health Sciences (NIEHS)

TrialNOT YET RECRUITING
Apr 2026NHLBI-Emory Advanced Cardiac CT Reconstruction

National Heart, Lung, and Blood Institute (NHLBI)

TrialNOT YET RECRUITING
Feb 2026MultiCPR: The Influence of Resuscitation on History Recall

Medical University of Vienna — NA

TrialRECRUITING
Dec 2025Integrated Suicide & Trauma Therapy for Suicide Risk

Unity Health Toronto — NA

TrialRECRUITING
Sep 2025Contrast-enhanced Mammography in Women With a Personal History of Breast Cancer and Dense Breast Tissue: Benefit?

Jean Seely — NA

TrialNOT YET RECRUITING
Apr 2025AMIE's Clinical Conversational Abilities in an Urgent Care Setting

Beth Israel Deaconess Medical Center

TrialENROLLING BY INVITATION
Feb 2025Variations in the Hemostatic System Induced by a Standardized Walking Test

Centre Hospitalier Universitaire de Nīmes — NA

TrialRECRUITING
Dec 2024SMART-CPT for PTSD/Concussion Implementation

San Diego Veterans Healthcare System — NA

TrialENROLLING BY INVITATION
Dec 2024In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme

LifeBridge Health

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Holt-Oram syndrome.

View clinical trials →

No actively recruiting trials found for Holt-Oram syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Holt-Oram syndrome community →

Specialists

22 foundView all specialists →
EP
Evelien Dekker, MD PhD
Specialist
PI on 3 active trials
RM
Ramya M Ramaswami, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 10 active trials
LM
Leslie G Biesecker, M.D.
BETHESDA, MD
Specialist
PI on 8 active trials
BM
Brian P Brooks, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 8 active trials
MM
Matthew J Memoli, M.D.
BETHESDA, MD
Specialist
PI on 6 active trials
MM
Mary Spellman, MD
SAN FRANCISCO, CA
Specialist
PI on 4 active trials
WM
Walter García, MD
Specialist
PI on 3 active trials1 Holt-Oram syndrome publication
XP
Xiulan Zhang, MD, PhD
Specialist
PI on 2 active trials
DM
Debra J Ehrlich, M.D.
GLENDALE, AZ
Specialist
PI on 3 active trials
MM
Marc G Ghany, M.D.
BETHESDA, MD
Specialist
PI on 4 active trials
PM
Peter D Crompton, M.D.
ROCKVILLE, MD
Specialist
PI on 3 active trials
BP
Brett G Jeffrey, Ph.D.
CHATTAHOOCHEE, FL
Specialist
PI on 4 active trials
SP
Silvina G Horovitz, Ph.D.
Specialist
PI on 2 active trials
TM
Troy J Plumb, MD
OMAHA, NE
Specialist
PI on 2 active trials
LC
Leorey N Saligan, C.R.N.P.
Specialist
PI on 3 active trials
LM
Leonardo G Cohen, M.D.
Specialist
PI on 2 active trials
LM
Lawrence S Kirschner, M.D.
Research Triangle Park, North Carolina
Specialist

Rare Disease Specialist

PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Holt-Oram syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Holt-Oram syndromeForum →

No community posts yet. Be the first to share your experience with Holt-Oram syndrome.

Start the conversation →

Latest news about Holt-Oram syndrome

Disease timeline:

New recruiting trial: Gestational Diabetes After Gastric Bypass Surgery

A new clinical trial is recruiting patients for Holt-Oram syndrome

New recruiting trial: Development of 3T Magnetic Resonance Research Methods for NIA Studies

A new clinical trial is recruiting patients for Holt-Oram syndrome

New recruiting trial: Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)

A new clinical trial is recruiting patients for Holt-Oram syndrome

New recruiting trial: Natural History of Advanced Chronic Liver Diseases

A new clinical trial is recruiting patients for Holt-Oram syndrome

New recruiting trial: Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates

A new clinical trial is recruiting patients for Holt-Oram syndrome

New recruiting trial: Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination

A new clinical trial is recruiting patients for Holt-Oram syndrome

New recruiting trial: Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer

A new clinical trial is recruiting patients for Holt-Oram syndrome

New recruiting trial: Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors

A new clinical trial is recruiting patients for Holt-Oram syndrome

New recruiting trial: Natural History Study of Kaposi Sarcoma

A new clinical trial is recruiting patients for Holt-Oram syndrome

New recruiting trial: Natural History Study and Establishment of a Biorepository-TANGO2-related Disorder

A new clinical trial is recruiting patients for Holt-Oram syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Holt-Oram syndrome

What is Holt-Oram syndrome?

Holt-Oram syndrome (HOS), also known as heart-hand syndrome or atriodigital dysplasia, is a rare genetic disorder characterized by upper limb skeletal abnormalities and congenital heart defects. It is caused by mutations in the TBX5 gene located on chromosome 12q24.1, which encodes a transcription factor critical for the development of the heart and upper limbs during embryonic growth. The condition affects both the musculoskeletal and cardiovascular systems, with highly variable expressivity even within the same family. Upper limb abnormalities are present in all affected individuals and ran

How is Holt-Oram syndrome inherited?

Holt-Oram syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Holt-Oram syndrome typically begin?

Typical onset of Holt-Oram syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Holt-Oram syndrome?

22 specialists and care centers treating Holt-Oram syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.